Similarly, glioma stem cells (GSCs) rely on active HH/GLI signaling for their tumorigenic and clonogenic properties [72], as do highly malignant CSCs in pancreatic cancer, melanoma, leukemia and other aggressive entities with high medical need [73,74,75,76,77]. This evidence concerns the gene GLI1 and melanoma.